Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects (NSERC partnered)

University of Toronto

$263,123.00

ARRT: Adaptive and Robust Radiation Therapy treatment planning for lung cancer

EF 2010-11

Résumé
Lung cancer is the leading cause of cancer death in Canada and worldwide. Improving current methods of treatment is paramount to increasing survival and reducing the rising costs of managing this disease. Radiation therapy is a core technology used to treat lung cancer. Radiation is delivered to the patient using external beams of high energy x-rays aimed at the tumor. However, there are several challenges associated with delivering high quality treatments. First, since radiation damages healthy tissue, the amount of radiation delivered to the tumour is limited by the radiation tolerance of nearby organs such as the lung, heart, and spinal cord. Second, lung tumours are subject to irregular movements caused by patient breathing. As a result, the radiation beam may miss part of the target or may end up delivering increased dose to the healthy tissue. Third, the tumour's size, geometry and metabolic activity will change over the course of a typical multi-week treatment. Current clinical protocols typically do not adapt to these changes. The goal of our research is to improve the efficacy of radiation therapy treatments for lung cancer. In this project, we will address current limitations by developing a new treatment planning method based on sophisticated mathematical techniques. We will develop a mathematical model that optimizes treatments and, in comparison to traditional methods, allows more dose to be delivered to the tumour while keeping dose to the healthy tissues low. Our model will account for the presence of healthy lung tissue, the motion of the tumour during treatment, and the evolution of the tumour's characteristics over multiple weeks. We will test our methodology on clinical data, and we will develop protocols to ensure such advanced treatments can be delivered within the clinical constraints under which hospitals currently operate. Our collaborative team brings together researchers from both engineering and health sciences to pursue this innovative research project. In the long term, our technology has the potential to impact therapies for many types of cancer and to improve the health of cancer patients in Canada and worldwide.
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
222801
Name
Chan Timothy
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
ARRT: Adaptive and Robust Radiation Therapy treatment planning for lung cancer
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$263,123
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Radiation Therapy
Abstract
Lung cancer is the leading cause of cancer death in Canada and worldwide. Improving current methods of treatment is paramount to increasing survival and reducing the rising costs of managing this disease. Radiation therapy is a core technology used to treat lung cancer. Radiation is delivered to the patient using external beams of high energy x-rays aimed at the tumor. However, there are several challenges associated with delivering high quality treatments. First, since radiation damages healthy tissue, the amount of radiation delivered to the tumour is limited by the radiation tolerance of nearby organs such as the lung, heart, and spinal cord. Second, lung tumours are subject to irregular movements caused by patient breathing. As a result, the radiation beam may miss part of the target or may end up delivering increased dose to the healthy tissue. Third, the tumour's size, geometry and metabolic activity will change over the course of a typical multi-week treatment. Current clinical protocols typically do not adapt to these changes. The goal of our research is to improve the efficacy of radiation therapy treatments for lung cancer. In this project, we will address current limitations by developing a new treatment planning method based on sophisticated mathematical techniques. We will develop a mathematical model that optimizes treatments and, in comparison to traditional methods, allows more dose to be delivered to the tumour while keeping dose to the healthy tissues low. Our model will account for the presence of healthy lung tissue, the motion of the tumour during treatment, and the evolution of the tumour's characteristics over multiple weeks. We will test our methodology on clinical data, and we will develop protocols to ensure such advanced treatments can be delivered within the clinical constraints under which hospitals currently operate. Our collaborative team brings together researchers from both engineering and health sciences to pursue this innovative research project. In the long term, our technology has the potential to impact therapies for many types of cancer and to improve the health of cancer patients in Canada and worldwide.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chan, Timothy
Approvedterm
3 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $263,123~ $0~